Radiologic and clinical features of COPD patients with discordant pulmonary physiology -: Lessons from α1-antitrypsin deficiency

被引:46
作者
Holme, Jayne [1 ]
Stockley, Robert A. [1 ]
机构
[1] Univ Hosp Birmingham, NHS Fdn Trust, Birmingham, W Midlands, England
关键词
alpha(1)-antitrypsin deficiency; COPD; CT scanners; quality of life; respiratory function tests;
D O I
10.1378/chest.07-0341
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Subjects with COPD display heterogeneity in clinical, physiologic, and radiologic characteristics, which are thought to result from different pathophysiologic mechanisms. It is important to identify and understand specific phenotypes for patient management. We investigated differences in emphysema distribution and health status in alpha(I)-antitrypsin deficient subjects (PiZ) with discordant lung function. Method: CT scan densitometry, arterial oxygen tension, and St. George respiratory questionnaire scores were compared for 15 subjects with normal FEVI and lung diffusion capacity corrected for alveolar ventilation (KCO), both defined as > 80% predicted (group 1), 10 subjects with abnormal FEVI and normal KCO (group 2), 15 subjects with normal FEVI and abnormal KCO (group 3), and 10 subjects with both an abnormal FEVI and KCO (group 4). Results: Group 2 subjects had the greatest predominance of basal emphysema, and group 3 subjects had the least. Upper zone voxel index (ie, the percentage of voxels < -910 Hounsfield units) was greater in all groups with abnormal lung function (p = 0.003, 0.044, and < 0.001, respectively), indicating more upper zone emphysema than in subjects with normal lung function. Lower zone voxel index was increased in groups 2 and 4 compared to groups 1 and 3. Groups 2 and 4 had a lower Pao(2) (P < 0.001) than the other groups. All groups with abnormal lung function had a worse quality of life than those with normal lung function. Conclusion: Abnormality of FEVI is associated with basal-predominant emphysema, and abnormality of KCO is associated with relatively more upper zone emphysema; but, an isolated defect in KCO has a significant effect on health status.
引用
收藏
页码:909 / 915
页数:7
相关论文
共 50 条
  • [31] Alpha-1 antitrypsin deficiency prevalence in COPD patients in a specialized hospital in Buenos Aires, Argentina
    Menga, Guillermo
    Sorroche, Patricia
    Saez, Maria Soledad
    Moncalvo, Juan Jose
    Fernandez, Martin Eduardo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] Designing Clinical Trials in "Regular" COPD Versus Alpha-1 Antitrypsin Deficiency-Associated COPD: "More Alike Than Unalike?"
    Stoller, James K.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2022, 9 (01): : 95 - 102
  • [33] Activity of α1-Antitrypsin and Some Lysosomal Enzymes in the Blood Serum of Patients with Chronic Obstructive Pulmonary Disease after Smoking Cessation
    Wozniak, Bartosz
    Wozniak, Alina
    Konca, Jacek
    Gorecki, Dariusz
    Mila-Kierzenkowska, Celestyna
    Szpinda, Michal
    Sutkowy, Pawel
    Wesolowski, Roland
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [34] Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis
    Campos, Michael A.
    Runken, Michael C.
    Davis, Angela M.
    Johnson, Michael P.
    Stone, Glenda A.
    Buikema, Ami R.
    ADVANCES IN THERAPY, 2018, 35 (04) : 467 - 481
  • [35] Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency
    da Cruz, Thais Ferrari
    Rufino, Rogerio
    Lopes, Agnaldo Jose
    Noronha, Arnaldo
    Anselmo, Fernando Medeiros
    Costa, Claudia Henrique
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2267 - 2274
  • [36] Proteinase 3 activity is present in sputum from subjects with alpha-1-antitrypsin deficiency (AATD) and COPD
    Sinden, Nicola
    Stockley, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [37] Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
    Carleo, Alfonso
    Chorostowska-Wynimko, Joanna
    Koeck, Thomas
    Mischak, Harald
    Czajkowska-Malinowska, Malgorzata
    Rozy, Adriana
    Welte, Tobias
    Janciauskiene, Sabina
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 829 - 837
  • [38] Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
    Fahndrich, Sebastian
    Biertz, Frank
    Watz, Henrik
    Welte, Tobias
    Karch, Annika
    Koch, Armin
    Kauczor, Hans-Ulrich
    Jorres, Rudolf
    Vogelmeier, Claus
    Bals, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [39] Prevalence of alpha-1 antitrypsin deficiency in patients with acute exacerbation of chronic obstructive pulmonary disease: Insights from a prospective study
    Rayees, A. K.
    Chetambath, Ravindran
    Ibrahim, Ramseena
    Kumar, Anoop
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (06) : 2354 - 2356
  • [40] The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients Update from Central Eastern European (CEE) AAT Network
    Chorostowska-Wynimko, Joanna
    Kubincova, Anna
    Yanev, Nikolay
    Ulmeanu, Ruxandra
    Struniawski, Radoslaw
    Pobeha, Pavol
    Kyuchukov, Nikolay
    Deleanu, Oana
    Poplawska-VVisniewska, Beata
    Tkacova, Ruzena
    Ivanov, Yavor
    Mihaltan, Florin
    Valiulis, Arunas
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44